All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Cost of A Private Drug Plan Claim

IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis.

Learn more | View

Developing a Canadian managed entry approach for new innovation: What can Canada learn from Europe?

Many new therapies coming to the market are not well served by the traditional drug reimbursement approaches currently employed by Canada’s public plans. A growing number of European regulatory authorities have been using novel managed entry agreements (MEA) and innovative access agreements (IAA) to accelerate approval times and improve availability to patients.

Learn more | View


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.